HomeCompareGSHRF vs JNJ

GSHRF vs JNJ: Dividend Comparison 2026

GSHRF yields 185.19% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GSHRF wins by $76.98M in total portfolio value
10 years
GSHRF
GSHRF
● Live price
185.19%
Share price
$1.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.00M
Annual income
$37,339,999.80
Full GSHRF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GSHRF vs JNJ

📍 GSHRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGSHRFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GSHRF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GSHRF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GSHRF
Annual income on $10K today (after 15% tax)
$15,740.74/yr
After 10yr DRIP, annual income (after tax)
$31,738,999.83/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, GSHRF beats the other by $31,738,296.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GSHRF + JNJ for your $10,000?

GSHRF: 50%JNJ: 50%
100% JNJ50/50100% GSHRF
Portfolio after 10yr
$38.51M
Annual income
$18,670,413.79/yr
Blended yield
48.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GSHRF
No analyst data
Altman Z
21.1
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GSHRF buys
0
JNJ buys
0
No recent congressional trades found for GSHRF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGSHRFJNJ
Forward yield185.19%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$77.00M$20.0K
Annual income after 10y$37,339,999.80$827.78
Total dividends collected$72.25M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GSHRF vs JNJ ($10,000, DRIP)

YearGSHRF PortfolioGSHRF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$29,219$18,518.52$10,676$355.77+$18.5KGSHRF
2$81,832$50,568.57$11,407$389.39+$70.4KGSHRF
3$219,923$132,362.17$12,198$426.53+$207.7KGSHRF
4$567,767$332,449.13$13,056$467.62+$554.7KGSHRF
5$1,409,633$802,122.93$13,987$513.12+$1.40MGSHRF
6$3,369,509$1,861,201.75$14,998$563.56+$3.35MGSHRF
7$7,763,238$4,157,863.45$16,098$619.52+$7.75MGSHRF
8$17,259,544$8,952,878.98$17,295$681.69+$17.24MGSHRF
9$37,069,956$18,602,243.94$18,599$750.82+$37.05MGSHRF
10$77,004,853$37,339,999.80$20,022$827.78+$76.98MGSHRF

GSHRF vs JNJ: Complete Analysis 2026

GSHRFStock

Goldshore Resources Inc., a junior gold development company, engages in the acquisition, exploration, and evaluation of natural resource properties in Canada. It owns the Moss Lake gold project consisting of 3 contiguous mining claims located in Ontario. The company is headquartered in Vancouver, Canada.

Full GSHRF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GSHRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GSHRF vs SCHDGSHRF vs JEPIGSHRF vs OGSHRF vs KOGSHRF vs MAINGSHRF vs ABBVGSHRF vs MRKGSHRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.